Skip to content
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO […]
BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices Read More »
National Institutes of Health (NIH) Director Jay Bhattacharya acknowledged there are no studies indicating a link between any vaccine and autism as Senators pushed
NIH Director says no studies link vaccines and autism in hearing on modernization Read More »
The Biotechnology Innovation Organization (BIO) hailed inclusion of a bill to encourage new treatments for children with rare diseases and measures targeting reform of
BIO lauds passage of PPRV reauthorization and legislation on PBM reform Read More »
Maintaining a world-leading biotech industry keeps Americans safer and its economy stronger. Appropriate federal actions can support this leadership, the Biotechnology Innovation Organization (BIO)
BIO tells Congress how to maintain US biotech leadership Read More »
In 2020, the Milken Institute launched the FasterCures LeadersLink Program to build capacity and support the personal development of an emerging cadre of leaders
Program harnesses the power of mentorship for patient organization leaders Read More »
In an initiative to accelerate capital formation for biotech innovation, the Biotechnology Innovation Organization (BIO) on Jan. 7 launched the BIO Investment Council (BIC),
BIO Investment Council will bring together VC and small biotechs to boost innovation Read More »
The Biotechnology Innovation Organization (BIO) warned that new changes in federal recommendations for the childhood vaccination schedule are unscientific and put children’s health at
BIO warns of risks from change to CDC’s vaccine recommendations Read More »
The use of AI tools in the workplace is on the rise. This trend is equally true in the arena of patent practice. However,
Using AI In patent practice: Practical and ethical issues Read More »
The post-COVID era has been especially hard on patent lawyers working in the biopharma space. “I don’t think it’s an accident that during the
BIO IP Conference looks at academics and perceptions of IP Read More »
Patient advocates retold emotional stories of lives saved, changed—or at risk—as they discussed one of the most important factors enabling breakthroughs in fighting rare
Patient advocates urge action on PPRV to help fight rare disease Read More »
